LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 81.05 | 84.90 | 1457 | 8863 | 0.1644 | 0.5279 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 81.05 | 84.90 | 1441 | 8863 | 0.1626 | 0.5254 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 81.05 | 84.90 | 1454 | 8863 | 0.1640 | 0.5274 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.75 | 84.90 | 1442 | 8621 | 0.1673 | 0.5294 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.75 | 84.90 | 1477 | 8621 | 0.1713 | 0.5349 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.75 | 84.90 | 1447 | 8621 | 0.1678 | 0.5302 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.75 | 84.90 | 1462 | 8621 | 0.1696 | 0.5326 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 84.45 | 84.90 | 1426 | 8254 | 0.1728 | 0.5330 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 84.45 | 84.90 | 1473 | 8254 | 0.1784 | 0.5406 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 84.45 | 84.90 | 1436 | 8254 | 0.1740 | 0.5346 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 84.45 | 84.90 | 1454 | 8254 | 0.1761 | 0.5375 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 86.16 | 84.90 | 1393 | 8141 | 0.1711 | 0.5295 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 86.16 | 84.90 | 1451 | 8141 | 0.1782 | 0.5391 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 86.16 | 84.90 | 1441 | 8141 | 0.1770 | 0.5374 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 86.16 | 84.90 | 1456 | 8141 | 0.1788 | 0.5399 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 87.86 | 84.90 | 1353 | 7680 | 0.1762 | 0.5311 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 87.86 | 84.90 | 1480 | 7680 | 0.1927 | 0.5524 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 87.86 | 84.90 | 1436 | 7680 | 0.1870 | 0.5452 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 87.86 | 84.90 | 1453 | 7680 | 0.1892 | 0.5480 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 89.57 | 84.90 | 1355 | 7494 | 0.1808 | 0.5350 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 89.57 | 84.90 | 1478 | 7494 | 0.1972 | 0.5558 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 89.57 | 84.90 | 1449 | 7494 | 0.1933 | 0.5510 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 89.57 | 84.90 | 1463 | 7494 | 0.1952 | 0.5533 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 91.27 | 84.90 | 1339 | 7420 | 0.1805 | 0.5337 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 91.27 | 84.90 | 1472 | 7420 | 0.1984 | 0.5564 | MN20160318_Q02 | I09 |